TickerFactsScreenerDevelopers

Corvus Pharmaceuticals, Inc. (CRVS) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2014: -$159.0K2015: -$31.10M2016: $132.80M2017: $84.83M2018: $110.34M2019: $71.11M2020: $72.15M2021: $97.16M2022: $56.12M2023: $38.68M2024: $32.57M2025: $61.20M$61.20M
2014Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$61.20M+87.9%
2024$32.57M-15.8%
2023$38.68M-31.1%
2022$56.12M-42.2%
2021$97.16M+34.7%
2020$72.15M+1.5%
2019$71.11M-35.6%
2018$110.34M+30.1%
2017$84.83M-36.1%
2016$132.80M+527.0%
2015-$31.10M-19460.4%
2014-$159.0K—